Sacral Neuromodulation for Chronic Pelvic Pain
RecruitingNCT06150599Phase: NAStarted 2025-06-30
Summary
Sacral neuromodulation (SNM) is a safe, effective, and minimally invasive FDA approved treatment for urinary and fecal incontinence, urinary frequency, urgency, and urinary retention. In this study we
Eligibility
Sex
FEMALE
Min Age
22 Years
Max Age
70 Years
Locations
Corewell Health William Beaumont University HospitalRoyal Oak, Michigan, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06150599